Weekly watch — every Wednesday

Clinical genomics, read and reviewed for you

Every week, the most relevant publications in constitutional genetics, hereditary cancer, pharmacogenomics and bioinformatics — curated, scored against a public grid and reviewed by a medical biologist. Free, ad-free.

770
articles reviewed
268
genes covered
19
weeks published
~1,100
screened / week

Every week, ~1,100 publications are screened down to a curated, scored selection — over ~21,300 publications examined since launch.

This week on Geno'X

Four domains, one report per week each.

Featured this week· Hereditary cancer genetics · 10/10
TP53Li-Fraumeni syndrome and clonal haematopoiesis

Apparently pathogenic *TP53* variants found in blood may come from the germline or from somatic clonal expansions, which complicates risk interpretation. Using blood-derived whole-exome data from 469,391 UK Biobank participants, the authors combined variant allele fraction (VAF) with haplotype-sharing analysis to separate germline from somatic *TP53* variants. Germline variants clustered at sites linked to partial loss of p53 function and lower penetrance, whereas classic Li-Fraumeni alleles appeared to be predominantly somatically acquired. Classic alleles at high VAF carried a markedly increased risk of haematological malignancy but not of solid tumours, reflecting the contribution of large *TP53*-mutant clonal expansions. The prevalence of clonal expansion correlated with missense variant pathogenicity, so somatic activity provides an informative in vivo proxy for functional impact.

Observatory

The watch in numbers

Selection funnel, score distribution, most-covered genes — the full curation mechanics, in the open.

Explore the watch in numbers
~1,100
screened / wk
3.4 %
selected
268
genes

How it works

1. Exhaustive collection

Every week, PubMed, around a hundred specialty journals and bioRxiv/medRxiv preprints are screened across all 4 domains.

2. Transparent scoring

Each article is scored out of 10 against a public 5-criteria grid — clinical impact first. The score breakdown is shown on every article page.

3. Signed expert analysis

Every selected article is read and reviewed by a medical biologist: bilingual FR/EN summary and critical perspective — no black-box generated digest.

The full scoring grid is public: see the methodology.

Who is behind Geno'X?

Dr Thibaut Benquey

Geno'X Veille is published by Dr Thibaut Benquey, a medical biologist specializing in constitutional genomics (WGS/WES) — from rare disease diagnosis to the clinical applications of next-generation sequencing. Every article is personally curated, scored and reviewed: no mass-generated content, no black box.

Follow on LinkedIn

Why it's free

Geno'X Veille is a personal project — no ads, no sponsors, no sponsored content. No data is ever sold. The goal isn't commercial: it's to make clinical-genomics literature monitoring accessible to the whole community — biologists, geneticists, residents, genetic counsellors.

If you find the project useful, you can support hosting and curation time via Ko-fi — entirely optional.

Support on Ko-fi
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime